In this drug factsheet:DIN (Drug Identification Number)
|02243045 ||ZOMIG RAPIMELT 2.5MG ORALLY DISINTEGRATING TABLET|
How does this medication work? What will it do for me?
Zolmitriptan belongs to a class of medications known as 5-hydroxytryptamine agonists (also called triptans). It is used to treat migraine headaches with or without aura (warning signs that occur prior to the onset of a migraine headache). The pain of migraine headaches is thought to be caused by dilated blood vessels inside the head. Zolmitriptan relieves migraine headaches by constricting these blood vessels.
Zolmitriptan is not recommended for other types of headache or for headache prevention. In most people, zolmitriptan eliminates or reduces the symptoms of migraines including headache, nausea, vomiting, and sensitivity to light and sound.
Your doctor may have suggested this medication for conditions other than the ones listed in these drug information articles. As well, some forms of this medication may not be used for all of the conditions discussed here. If you have not discussed this with your doctor or are not sure why you are taking this medication, speak to your doctor. Do not stop taking this medication without consulting your doctor.
Do not give this medication to anyone else, even if they have the same symptoms as you do. It can be harmful for people to take this medication if their doctor has not prescribed it.
How should I use this medication?
The recommended adult dose is a single dose of 2.5 mg. If the migraine headache returns, the dose may be repeated after 2 hours. You should not take a total dose of more than 10 mg in any 24-hour period. If a dose has not helped your headache at all, do not take a second dose without first consulting a doctor.
Zolmitriptan dispersible tablets should be used as follows:
- Peel the blister pack open as shown on the foil (do not push the tablets through the foil).
- Place the tablet on the tongue, where it will dissolve with your saliva. Because this tablet is dispersible, you do not need to take it with water.
- Do not split the tablet in half.
It is important to use this medication exactly as recommended by your doctor.
Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are taking the medication without consulting your doctor.
Store this medication at room temperature, protect it from moisture, and keep it out of the reach of children.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
What form(s) does this medication come in?
Each orally dispersible, white, round uncoated tablet, intagliated "Z" on one side with a bevelled-edge, contains zolmitriptan 2.5 mg. Nonmedicinal ingredients: aspartame, citric acid, colloidal silicon dioxide, crospovidone, magnesium stearate, mannitol, microcrystalline cellulose, orange flavour, and sodium bicarbonate.
Who should NOT take this medication?
Do not use zolmitriptan if you:
- are allergic to zolmitriptan or any ingredients of the medication
- are taking monoamine oxidase (MAO) inhibitors (e.g., phenelzine, tranylcypromine) or have taken them within the past 2 weeks
- do not have a clear diagnosis of migraine
- have angina (chest pain), including Prinzmetal's angina (coronary vasospasm)
- have blood vessel disease (e.g., ischemic bowel disease, Raynaud's syndrome, stroke, transient ischemic attacks [TIAs])
- have certain types of migraine headaches (including hemiplegic, basilar, or ophthalmoplegic migraine)
- have had a heart attack
- have heart disease (e.g., heart valve disease, ischemic heart disease, abnormal heart rhythms, congenital heart disease)
- have severe or uncontrolled high blood pressure
- have taken another 5-hydroxytryptamine agonist (i.e., naratriptan, sumatriptan, rizatriptan) in the previous 24 hours
- have taken ergotamine-containing or ergot-type medications (such as dihydroergotamine, ergotamine, or methysergide) in the previous 24 hours